Parkman Healthcare Partners’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
228,271
-122,149
| -35% | -$1.39M | 0.3% | 75 |
|
|
2025
Q1 | $4.16M | Sell |
350,420
-181,752
| -34% | -$2.16M | 0.49% | 57 |
|
|
2024
Q4 | $10M | Buy |
532,172
+93,201
| +21% | +$1.76M | 1.34% | 30 |
|
|
2024
Q3 | $9.86M | Sell |
438,971
-35,708
| -8% | -$802K | 1.26% | 27 |
|
|
2024
Q2 | $9.91M | Buy |
474,679
+224,679
| +90% | +$4.69M | 1.33% | 26 |
|
|
2024
Q1 | $3.68M | Buy |
+250,000
| New | +$3.68M | 0.45% | 66 |
|
|
2022
Q2 | – | Sell |
-20,663
| Closed | -$289K | – | 85 |
|
|
2022
Q1 | $289K | Sell |
20,663
-67,161
| -76% | -$939K | 0.08% | 79 |
|
|
2021
Q4 | $2.54M | Buy |
+87,824
| New | +$2.54M | 0.56% | 47 |
|